| 000 | 01770 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250511181249.0 | ||
| 264 | 0 | _c19920911 | |
| 008 | 199209s 0 0 eng d | ||
| 022 | _a1053-0770 | ||
| 024 | 7 |
_a10.1016/1053-0770(92)90006-s _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlacke, W E | |
| 245 | 0 | 0 |
_aEffect of dexmedetomidine, an alpha 2-adrenergic agonist, in the isolated heart. _h[electronic resource] |
| 260 |
_bJournal of cardiothoracic and vascular anesthesia _cAug 1992 |
||
| 300 |
_a418-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtrial Function, Left _xdrug effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEpinephrine _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aLung |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedetomidine |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aNorepinephrine _xblood |
| 650 | 0 | 4 |
_aPrazosin _xpharmacology |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVenous Pressure _xdrug effects |
| 700 | 1 | _aFlacke, J W | |
| 700 | 1 | _aBlow, K D | |
| 700 | 1 | _aMcIntee, D F | |
| 700 | 1 | _aBloor, B C | |
| 773 | 0 |
_tJournal of cardiothoracic and vascular anesthesia _gvol. 6 _gno. 4 _gp. 418-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/1053-0770(92)90006-s _zAvailable from publisher's website |
| 999 |
_c1360488 _d1360488 |
||